Xeomin FDA Approval History
FDA Approved: Yes (First approved July 30, 2010)
Brand name: Xeomin
Generic name: incobotulinumtoxinA
Dosage form: Injection
Company: Merz Pharmaceuticals
Treatment for: Cervical Dystonia, Blepharospasm, Facial Wrinkles, Upper Limb Spasticity, Excessive Salivation
Xeomin (incobotulinumtoxinA) is a botulinum toxin type A for the treatment of cervical dystonia, blepharospasm, glabellar lines, upper limb spasticity, and excessive drooling.
Development Timeline for Xeomin
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.